| Fund Name | Location |
| Cahill Goron &Reindel | New York, New York, United States |
| Decacorn Capital | Central Region, Singapore, Singapore |
| ERA Capital Partners | Dallas, Texas, United States |
| Goat Rodeo Capital | California, San Francisco, United States |
| Hamilton Investment Partners | New York, New York, United States |
| IG Business Angels | Argentina, Buenos Aires, Distrito Federal |
| Jefferson Health System | Pennsylvania, Philadelphia, United States |
| Jinan Yihulian Touzi Guanli Youxian Gongsi | China, Jinan, Shandong |
| KB Securities | Seoul, Seoul-t'ukpyolsi, South Korea |
| Lasa Hengyijufu | China, Lhasa, Tibet |
| Liahona Ventures | Austin, Texas, United States |
| MindWorks Ventures | China, Hong Kong, Hong Kong Island |
| Nextech Venture | Switzerland, Zürich, Zurich |
| Ocean Capital | Rhode Island, United States, Warwick |
| Qinding Investment Management | China, Hangzhou, Zhejiang |
| RMR Capital | Las Vegas, Nevada, United States |
| SCADpro Fund | - |
| Shanghai Lingyue Jiuyuan Chuangye Touzi Zhongxin (Youxian Hehuo) | China, Shanghai |
| Waisbein Fund | - |
| WebStart Bristol | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoImmune | $56M | 09 Sep 2020 | Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OncoImmune | $56M | 09 Sep 2020 | Maryland, United States |
